FOR IMMEDIATE RELEASE: 14 March 2018
Dr. Markus Butz-Ostendorf
Biomax Informatics AG
Tel: +49 89 895574-0
Email: markus.butz-ostendorf@biomax.com
Biomax Informatics announces pre-launch of its NeuroXM™ Brain Science Suite Planegg, Germany — Biomax Informatics AG, a leading bioinformatics company with 20 years in the market, makes an important step toward new markets today. With competence in knowledge management for the life sciences, Biomax is about to offer its first commercial product for brain science. The NeuroXM™ Brain Science Suite is a unique collection of tools and features for working with multimodal high-dimensional brain data ready for clinical use. The NeuroXM Brain Science Suite is a unique collection of tools and features, which make the lives of everyone working with multimodal brain science data — from neuroimaging to genetics and transcriptomics — easier. It creates a unified knowledge model containing a tremendous amount of heterogeneous data available for the brain, thus making it easily manageable in daily clinical routines. It connects patient brain data to public knowledge in databases, atlases and ontologies for automatic annotation with methodological metainformation so that they become invaluable for any clinician and scientist working with brain scans on a daily basis. The NeuroXM suite supports every brain science task from standardizing preprocessing workflows to cataloging and sharing brain data to research-driven exploration and assessments of high-dimensional brain data sets. It is fully based on the BioXM™ Knowledge Management Environment by Biomax, which has been successful in 24/7 operation at a clinical data center. The NeuroXM suite complies with the same data security standards and reliability of the BioXM technology and is ready to be used in clinical settings. Customers can stay tuned on the latest developments and follow the final steps towards the launch of the NeuroXM suite, the novel Biomax brain science product, set for final release in mid-2018. Biomax will be present at the biannual meeting of the German Biological Psychiatric Society (http://www.dgbp2018.de/) at the prestigious Psychiatric University Hospital of Heidelberg in Campus Bergheim (March 14–16, 2018). Visit Biomax at poster presentation P41 “Risk Management in First Episode Psychosis Patients” on Thursday, March 15, 2018 (http://www.dgbp2018.de/dgbp2018_2.html#pos). Biomax will present results from the EUfunded research project “Neuroimaging platform for characterization of metabolic comorbidities in psychotic disorders” (METSY) (http://www.metsy.eu/), which is one of the sources of the NeuroXM Brain Science Suite idea.
About Biomax Biomax Informatics AG provides computational solutions for better decision making and knowledge management in the life sciences. They help customers generate value by integrating information from proprietary and public resources to enable a knowledge-based approach to developing innovative life science products. Biomax’s worldwide customer community includes companies and research organizations that are successful in healthcare, drug discovery, diagnostics, fine chemicals, food and plant production, and synthetic biology. For more information, visit www.biomax.com